Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 210

1.

Inhibition of recombinant human carboxylesterase 1 and 2 and monoacylglycerol lipase by chlorpyrifos oxon, paraoxon and methyl paraoxon.

Crow JA, Bittles V, Herring KL, Borazjani A, Potter PM, Ross MK.

Toxicol Appl Pharmacol. 2012 Jan 1;258(1):145-50. doi: 10.1016/j.taap.2011.10.017. Epub 2011 Nov 4.

2.

Covalent inhibition of recombinant human carboxylesterase 1 and 2 and monoacylglycerol lipase by the carbamates JZL184 and URB597.

Crow JA, Bittles V, Borazjani A, Potter PM, Ross MK.

Biochem Pharmacol. 2012 Nov 1;84(9):1215-22. doi: 10.1016/j.bcp.2012.08.017. Epub 2012 Aug 27.

3.

Concentration-dependent interactions of the organophosphates chlorpyrifos oxon and methyl paraoxon with human recombinant acetylcholinesterase.

Kaushik R, Rosenfeld CA, Sultatos LG.

Toxicol Appl Pharmacol. 2007 Jun 1;221(2):243-50. Epub 2007 Mar 24.

4.

Inactivation of lipid glyceryl ester metabolism in human THP1 monocytes/macrophages by activated organophosphorus insecticides: role of carboxylesterases 1 and 2.

Xie S, Borazjani A, Hatfield MJ, Edwards CC, Potter PM, Ross MK.

Chem Res Toxicol. 2010 Dec 20;23(12):1890-904. doi: 10.1021/tx1002194.

5.

Inhibition of carboxylesterase 1 is associated with cholesteryl ester retention in human THP-1 monocyte/macrophages.

Crow JA, Middleton BL, Borazjani A, Hatfield MJ, Potter PM, Ross MK.

Biochim Biophys Acta. 2008 Oct;1781(10):643-54. doi: 10.1016/j.bbalip.2008.07.005. Epub 2008 Aug 5.

6.

Interaction of the serine hydrolase KIAA1363 with organophosphorus agents: Evaluation of potency and kinetics.

Ross MK, Pluta K, Bittles V, Borazjani A, Allen Crow J.

Arch Biochem Biophys. 2016 Jan 15;590:72-81. doi: 10.1016/j.abb.2015.11.034. Epub 2015 Nov 23.

8.
9.

Interactive toxicity of the organophosphorus insecticides chlorpyrifos and methyl parathion in adult rats.

Karanth S, Liu J, Olivier K Jr, Pope C.

Toxicol Appl Pharmacol. 2004 Apr 15;196(2):183-90.

PMID:
15081265
10.
12.

Comparison of chlorpyrifos-oxon and paraoxon acetylcholinesterase inhibition dynamics: potential role of a peripheral binding site.

Kousba AA, Sultatos LG, Poet TS, Timchalk C.

Toxicol Sci. 2004 Aug;80(2):239-48. Epub 2004 May 12.

PMID:
15141101
13.

Inhibition of carboxylesterase activity of THP1 monocytes/macrophages and recombinant human carboxylesterase 1 by oxysterols and fatty acids.

Crow JA, Herring KL, Xie S, Borazjani A, Potter PM, Ross MK.

Biochim Biophys Acta. 2010 Jan;1801(1):31-41. doi: 10.1016/j.bbalip.2009.09.002. Epub 2009 Sep 15.

14.

The cannabinoid receptor antagonist AM251 increases paraoxon and chlorpyrifos oxon toxicity in rats.

Liu J, Pope C.

Neurotoxicology. 2015 Jan;46:12-8. doi: 10.1016/j.neuro.2014.11.001. Epub 2014 Nov 20.

15.

Characterization of recombinant human carboxylesterases: fluorescein diacetate as a probe substrate for human carboxylesterase 2.

Wang J, Williams ET, Bourgea J, Wong YN, Patten CJ.

Drug Metab Dispos. 2011 Aug;39(8):1329-33. doi: 10.1124/dmd.111.039628. Epub 2011 May 3.

16.
17.

Purification of two rat hepatic proteins with A-esterase activity toward chlorpyrifos-oxon and paraoxon.

Pond AL, Chambers HW, Coyne CP, Chambers JE.

J Pharmacol Exp Ther. 1998 Sep;286(3):1404-11.

18.

The Relationship between PON1 phenotype and PON1-192 genotype in detoxification of three oxons by human liver.

Mutch E, Daly AK, Williams FM.

Drug Metab Dispos. 2007 Feb;35(2):315-20. Epub 2006 Nov 28.

19.

Serum paraoxonase and its influence on paraoxon and chlorpyrifos-oxon toxicity in rats.

Costa LG, McDonald BE, Murphy SD, Omenn GS, Richter RJ, Motulsky AG, Furlong CE.

Toxicol Appl Pharmacol. 1990 Mar 15;103(1):66-76.

PMID:
1690462

Supplemental Content

Support Center